...
首页> 外文期刊>FEBS Open Bio >Fructose 1-phosphate is the one and only physiological effector of the Cra (FruR) regulator of Pseudomonas putida
【24h】

Fructose 1-phosphate is the one and only physiological effector of the Cra (FruR) regulator of Pseudomonas putida

机译:1-磷酸果糖是恶臭假单胞菌Cra(FruR)调节剂的唯一且唯一的生理效应物

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Fructose-1-phosphate (F1P) is the preferred effector of the catabolite repressor/activator (Cra) protein of the soil bacterium Pseudomonas putida but its ability to bind other metabolic intermediates in vivo is unclear. The Cra protein of this microorganism (Cra^P^P) was submitted to mobility shift assays with target DNA sequences (the P"f"r"u"B promoter) and candidate effectors fructose-1,6-bisphosphate (FBP), glucose 6-phosphate (G6P), and fructose-6-phosphate (F6P). 1mM F1P was sufficient to release most of the Cra protein from its operators but more than 10mM of FBP or G6P was required to free the same complex. However, isothermal titration microcalorimetry failed to expose any specific interaction between Cra^P^P and FBP or G6P. To solve this paradox, transcriptional activity of a P"f"r"u"B-lacZ fusion was measured in wild-type and @DfruB cells growing on substrates that change the intracellular concentrations of F1P and FBP. The data indicated that P"f"r"u"B activity was stimulated by fructose but not by glucose or succinate. This suggested that Cra^P^P represses expression in vivo of the cognate fruBKA operon in a fashion dependent just on F1P, ruling out any other physiological effector. Molecular docking and dynamic simulations of the Cra-agonist interaction indicated that both metabolites can bind the repressor, but the breach in the relative affinity of Cra^P^P for F1P vs FBP is three orders of magnitude larger than the equivalent distance in the Escherichia coli protein. This assigns the Cra protein of P. putida the sole role of transducing the presence of fructose in the medium into a variety of direct and indirect physiological responses.
机译:1-磷酸果糖(F1P)是土壤细菌恶臭假单胞菌的分解代谢物阻遏物/激活物(Cra)蛋白的优选效应物,但其在体内结合其他代谢中间体的能力尚不清楚。该微生物的Cra蛋白(Cra ^ P ^ P)已通过目标DNA序列(P“ f” r“ u” B启动子)和候选效应子果糖1,6-双磷酸酯(FBP)进行了迁移迁移分析,葡萄糖6磷酸(G6P)和果糖6磷酸(F6P)。 1mM F1P足以从其操作员中释放大多数Cra蛋白,但要释放相同的复合物,则需要10mM以上的FBP或G6P。然而,等温滴定微量热法不能揭示Cra ^ P ^ P和FBP或G6P之间的任何特异性相互作用。为了解决这个矛盾,在生长在改变细胞内F1P和FBP浓度的底物上的野生型和@DfruB细胞中,测量了P” f” r” u” B-lacZ融合体的转录活性。数据表明果糖刺激了P” f” r” u” B活性,但葡萄糖或琥珀酸却没有。这表明Cra ^ P ^ P以仅依赖于F1P的方式抑制了同源的fruBKA操纵子的体内表达,排除了任何其他生理效应子。 Cra-激动剂相互作用的分子对接和动力学模拟表明,两种代谢物都可以结合阻遏物,但是Cra ^ P ^ P对F1P和FBP的相对亲和力的破坏比大肠杆菌中的等效距离大三个数量级。大肠杆菌蛋白。这将恶臭假单胞菌的Cra蛋白赋予将培养基中果糖的存在转导为多种直接和间接生理反应的唯一作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号